Pharmacokinetic differences between subcutaneous injection and intradermal microneedle delivery of protein therapeutics ScienceDirect BPC 157 is back in the conversation as a potential peptide to improve musculoskeletal tissue repair. One registered Phase 1 trial in healthy volunteers exists for an oral formulation (NCT02637284) Brandon Roberts Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing Cell and Tissue Research Springer Nature Link BPC 157 No Proof Required! Office for Science and Society McGill University BPC 157 Erectile Dysfunction Study: What the Evidence Actually Shows Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing Cell and Tissue Research Springer Nature Link